Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?

Expert Rev Gastroenterol Hepatol. 2018 May;12(5):435-438. doi: 10.1080/17474124.2018.1465818. Epub 2018 Apr 20.

Author

Alexander Khoruts¹

Affiliation

¹ a Division of Gastroenterology, Center for Immunology, BioTechnology Institute , University of Minnesota , Minneapolis , MN , USA.

PMID: 29667436
DOI: 10.1080/17474124.2018.1465818

No abstract available

Keywords: Clostridium difficile infection; fecal microbiota transplantation (FMT); microbial community; microbiota therapeutics; regulation.

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / therapeutic use
Clostridioides difficile / drug effects
Clostridioides difficile / pathogenicity*
Clostridium Infections / diagnosis
Clostridium Infections / microbiology
Clostridium Infections / therapy*
Drug Resistance, Bacterial
Fecal Microbiota Transplantation* / adverse effects
Gastrointestinal Microbiome* / drug effects
Host-Pathogen Interactions
Humans
Treatment Outcome

Substances

Anti-Bacterial Agents